Evidence map›Paper›PMID 41320221›Full record

ArticleBMJ open2025

Telerehabilitation for people with Parkinson's disease: protocol of a randomised clinical trial of mixed methods.

Raíssa Souza Taveira, Liliane Santos de Vasconcellos, Clarissa Fernandes Bezerra, Diogo Neres Aires, Adriel Kelvin Dias de Oliveira, Kaline de Oliveira Cariolando da Silva, Luciana Protásio de Melo, Tatiana Souza Ribeiro

Abstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Raíssa Souza TaveiraDepartment of Physiotherapy, Federal University of Rio Grande do Norte, Natal, Brazil raissa.taveira@ufrn.br.ORCID http://orcid.org/0009-0003-9455-0168
Liliane Santos de VasconcellosDepartment of Physiotherapy, Federal University of Rio Grande do Norte, Natal, Brazil.ORCID http://orcid.org/0000-0003-3921-0163
Clarissa Fernandes BezerraDepartment of Physiotherapy, Federal University of Rio Grande do Norte, Natal, Brazil.ORCID http://orcid.org/0000-0003-2729-6318
Diogo Neres AiresDepartment of Physiotherapy, Federal University of Rio Grande do Norte, Natal, Brazil.ORCID http://orcid.org/0009-0006-1935-090X
Adriel Kelvin Dias de OliveiraDepartment of Physiotherapy, Federal University of Rio Grande do Norte, Natal, Brazil.ORCID http://orcid.org/0000-0003-1326-5297
Kaline de Oliveira Cariolando da SilvaDepartment of Physiotherapy, Federal University of Rio Grande do Norte, Natal, Brazil.ORCID http://orcid.org/0009-0000-5840-8154
Luciana Protásio de MeloDepartment of Physical Therapy, Federal University of Rio Grande do Norte, Natal, Brazil.ORCID http://orcid.org/0000-0003-3320-9428
Tatiana Souza RibeiroDepartment of Physical Therapy, Federal University of Rio Grande do Norte, Natal, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTelerehabilitation (TR) programmes are increasingly recognised for their feasibility and potential benefits, such as eliminating travel time, reducing costs and providing a more comfortable rehabilitation experience at home. However, the comparative efficacy of remote physiotherapy compared with traditional in-person sessions for individuals with Parkinson's disease (PD) remains uncertain. This study aims to evaluate the effects of TR compared with in-person physiotherapy in individuals with PD, focusing on both motor and non-motor outcomes. METHODS AND ANALYSIS: This is a randomised, single-blind clinical trial with a mixed-methods approach. A total of 22 individuals diagnosed with PD will be randomly assigned to one of two groups. The experimental group will receive TR, consisting of remote physiotherapy sessions conducted once a week for 1 hour over a 4-month period. The control group will receive the same interventions in person. Interventions will include global muscle strengthening exercises, balance training, gait and motor coordination exercises, and cognitive training. The primary outcome will be motor function, measured using part III of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. Secondary outcomes will include cognition (Montreal Cognitive Assessment), gait (Functional Gait Assessment), mobility (Timed Up and Go Test) and quality of life (Parkinson's Disease Questionnaire). Data will be analysed using repeated measures analysis of variance to compare outcomes between groups across four assessment points (baseline, midpoint, postintervention and 2 months follow-up). Additionally, a qualitative phase will explore participants' perceptions and experiences regarding TR and in-person interventions, with assessments carried out 2 months after the completion of the 24-week interventions, through semistructured interviews that will be analysed using Bardin's Content Analysis technique. ETHICS AND DISSEMINATION: This protocol was approved by the Research Ethics Committee of the Federal University of Rio Grande do Norte (approval number: 5.553.701). All participants will provide written informed consent before inclusion. Results will be disseminated through peer-reviewed publications, scientific conferences and communication with participants and healthcare professionals. TRIAL REGISTRATION NUMBER: RBR-6h5knrj.

Indexed as

Exercise TherapyParkinson DiseasePhysical Therapy ModalitiesTelerehabilitationAgedFemaleHumansMaleMiddle AgedQuality of LifeRandomized Controlled Trials as TopicSingle-Blind MethodNeurophysiologyParkinson-s diseaseRehabilitation medicineTelemedicine

Identifiers

PMID41320221
PMCPMC12666072

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.